S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS

BACKGROUND: This study reports on clinical data from an 8-week open-label study of 20 HIV-seropositive individuals, diagnosed with Major Depressive Disorder (DSM-IV), who were treated with SAM-e (S-Adenosylmethionine). SAM-e may be a treatment alternative for the management of depression in a popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Shippy, R Andrew, Mendez, Douglas, Jones, Kristina, Cergnul, Irene, Karpiak, Stephen E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535560/
https://www.ncbi.nlm.nih.gov/pubmed/15538952
http://dx.doi.org/10.1186/1471-244X-4-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535560/
https://www.ncbi.nlm.nih.gov/pubmed/15538952
http://dx.doi.org/10.1186/1471-244X-4-38

Ejemplares similares